Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 348

1.

GABA-Induced GnRH Release Triggers Chordate Metamorphosis.

Hozumi A, Matsunobu S, Mita K, Treen N, Sugihara T, Horie T, Sakuma T, Yamamoto T, Shiraishi A, Hamada M, Satoh N, Sakurai K, Satake H, Sasakura Y.

Curr Biol. 2020 Mar 4. pii: S0960-9822(20)30176-7. doi: 10.1016/j.cub.2020.02.003. [Epub ahead of print]

PMID:
32220316
2.

Safety and effectiveness of direct oral anticoagulants for venous thromboembolism in patients with active cancer: a retrospective study.

Ogata M, Satake H, Ama Y, Hirabatake M, Ogata T, Yasui H, Hashida T.

Ann Oncol. 2019 Jul;30 Suppl 4:iv45. doi: 10.1093/annonc/mdz155.164. Epub 2019 Dec 4. No abstract available.

3.

Relationship between peripheral neuropathy and effectiveness in second-line chemotherapy for unresectable advanced gastric cancer: a prospective, observational, multicenter study protocol.

Tanioka H, Nagasaka T, Uno F, Inoue M, Okita H, Katata Y, Kanzaki H, Kuramochi H, Satake H, Shindo Y, Doi A, Nasu J, Yamashita H, Yamaguchi Y.

Ann Oncol. 2019 Jul;30 Suppl 4:iv31. doi: 10.1093/annonc/mdz155.113. Epub 2019 Dec 4. No abstract available.

4.

RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC).

Sunakawa Y, Nakamura M, Ishizaki M, Kataoka M, Satake H, Kitazono M, Yanagisawa H, Kawamoto Y, Kuramochi H, Ohori H, Nakamura M, Takahashi K, Maeda F, Komeno C, Takeuchi M, Fujii M, Yoshino T, Ichikawa W, Tsuji A.

Ann Oncol. 2019 Jul;30 Suppl 4:iv114. doi: 10.1093/annonc/mdz156.012. Epub 2019 Dec 4. No abstract available.

5.
6.

Distribution and physiological effect of enterin neuropeptides in the olfactory centers of the terrestrial slug Limax.

Matsuo R, Kobayashi S, Furuta A, Osugi T, Takahashi T, Satake H, Matsuo Y.

J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2020 Jan 29. doi: 10.1007/s00359-020-01400-2. [Epub ahead of print]

PMID:
31996989
7.

Mechanism of gamete shedding in starfish: Involvement of acetylcholine in extracellular Ca2+-dependent contraction of gonadal walls.

Mita M, Osugi T, Takahashi T, Watanabe T, Satake H.

Gen Comp Endocrinol. 2020 May 1;290:113401. doi: 10.1016/j.ygcen.2020.113401. Epub 2020 Jan 22.

PMID:
31981689
8.

Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.

Ooki A, Morita S, Iwamoto S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Suto T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.

Cancer Med. 2020 Mar;9(5):1779-1789. doi: 10.1002/cam4.2826. Epub 2020 Jan 21.

9.

[LAPAROSCOPIC RADICAL PROSTATECTOMY OF 926 PATIENTS AT THE HIROSHIMA ENDOUROLOGICAL ASSOCIATION].

Mita K, Kobatake K, Kohada Y, Naito M, Fukuoka K, Kitano H, Hisatome Y, Seno Y, Goto K, Goriki A, Shinmei S, Nagamatsu H, Iwamoto H, Fukada S, Satake H, Shimamoto T, Fukuhara H, Tamura K, Ohara S, Koda S, Mochizuki H, Kato M, Kadonishi Y, Mutaguchi K, Shigeta M.

Nihon Hinyokika Gakkai Zasshi. 2019;110(1):1-11. doi: 10.5980/jpnjurol.110.1. Japanese.

10.

Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma.

Nomura M, Oze I, Masuishi T, Yokota T, Satake H, Iwasawa S, Kato K, Andoh M.

Int J Clin Oncol. 2020 Jan 14. doi: 10.1007/s10147-020-01618-9. [Epub ahead of print]

PMID:
31938955
11.

Tachykinins: Neuropeptides That Are Ancient, Diverse, Widespread and Functionally Pleiotropic.

Nässel DR, Zandawala M, Kawada T, Satake H.

Front Neurosci. 2019 Nov 20;13:1262. doi: 10.3389/fnins.2019.01262. eCollection 2019. Review.

12.

Kinetic volume analysis on dynamic contrast-enhanced MRI of triple-negative breast cancer: associations with survival outcomes.

Hayashi Y, Satake H, Ishigaki S, Ito R, Kawamura M, Kawai H, Iwano S, Naganawa S.

Br J Radiol. 2020 Feb 1;93(1106):20190712. doi: 10.1259/bjr.20190712. Epub 2019 Dec 16.

PMID:
31821036
13.

Draft genome of Tanacetum cinerariifolium, the natural source of mosquito coil.

Yamashiro T, Shiraishi A, Satake H, Nakayama K.

Sci Rep. 2019 Dec 3;9(1):18249. doi: 10.1038/s41598-019-54815-6.

14.

Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.

Yuki S, Shinozaki K, Kashiwada T, Kusumoto T, Iwatsuki M, Satake H, Kobayashi K, Esaki T, Nakashima Y, Kawanaka H, Emi Y, Komatsu Y, Shimokawa M, Makiyama A, Saeki H, Oki E, Baba H, Mori M.

Cancer Chemother Pharmacol. 2020 Jan;85(1):217-223. doi: 10.1007/s00280-019-03991-3. Epub 2019 Nov 25.

PMID:
31768696
15.

Estimation of Extracellular Matrix Production Using a Cultured-Chondrocyte-Based Gate Ion-Sensitive Field-Effect Transistor.

Satake H, Sakata T.

Anal Chem. 2019 Dec 17;91(24):16017-16022. doi: 10.1021/acs.analchem.9b04789. Epub 2019 Dec 4.

PMID:
31749361
16.

Editorial: Endocrine and Neuroendocrine Systems of Invertebrate Deuterostomes.

Satake H, Larhammar D, Elphick MR.

Front Endocrinol (Lausanne). 2019 Nov 1;10:755. doi: 10.3389/fendo.2019.00755. eCollection 2019. No abstract available.

17.

A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).

Suzuki T, Sukawa Y, Imamura CK, Masuishi T, Satake H, Kumekawa Y, Funakoshi S, Kotaka M, Horie Y, Kawai S, Okuda H, Terazawa T, Kondoh C, Kato K, Yoshimura K, Ishikawa H, Hamamoto Y, Boku N, Takaishi H, Kanai T.

Clin Colorectal Cancer. 2020 Mar;19(1):13-21.e3. doi: 10.1016/j.clcc.2019.10.004. Epub 2019 Oct 23.

PMID:
31732439
18.

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).

Tanioka H, Nagasaka T, Uno F, Inoue M, Okita H, Katata Y, Kanzaki H, Kuramochi H, Satake H, Shindo Y, Doi A, Nasu J, Yamashita H, Yamaguchi Y.

BMC Cancer. 2019 Oct 11;19(1):941. doi: 10.1186/s12885-019-6163-6.

19.

Neuropeptides, Peptide Hormones, and Their Receptors of a Tunicate, Ciona intestinalis.

Satake H, Matsubara S, Shiraishi A, Yamamoto T, Osugi T, Sakai T, Kawada T.

Results Probl Cell Differ. 2019;68:107-125. doi: 10.1007/978-3-030-23459-1_5. Review.

PMID:
31598854
20.

Biocompatible and Na+-sensitive thin-film transistor for biological fluid sensing.

Ito K, Satake H, Mori Y, Tseng AC, Sakata T.

Sci Technol Adv Mater. 2019 Aug 20;20(1):917-926. doi: 10.1080/14686996.2019.1656516. eCollection 2019.

21.

The regulation of oocyte maturation and ovulation in the closest sister group of vertebrates.

Matsubara S, Shiraishi A, Osugi T, Kawada T, Satake H.

Elife. 2019 Oct 1;8. pii: e49062. doi: 10.7554/eLife.49062.

22.

Interfacial pH Behavior at a Cell/Gate Insulator Nanogap Induced by Allergic Responses.

Satake H, Sakata T.

ACS Omega. 2019 Aug 22;4(10):14255-14260. doi: 10.1021/acsomega.9b01872. eCollection 2019 Sep 3.

23.

Identification of a New Theca/Interstitial Cell-Specific Gene and Its Biological Role in Growth of Mouse Ovarian Follicles at the Gonadotropin-Independent Stage.

Aoyama M, Shiraishi A, Matsubara S, Horie K, Osugi T, Kawada T, Yasuda K, Satake H.

Front Endocrinol (Lausanne). 2019 Aug 14;10:553. doi: 10.3389/fendo.2019.00553. eCollection 2019.

24.

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer.

Munemoto Y, Nakamura M, Takahashi M, Kotaka M, Kuroda H, Kato T, Minagawa N, Noura S, Fukunaga M, Kuramochi H, Touyama T, Takahashi T, Miwa K, Satake H, Kurosawa S, Miura T, Mishima H, Sakamoto J, Oba K, Nagata N.

Eur J Cancer. 2019 Sep;119:158-167. doi: 10.1016/j.ejca.2019.07.006. Epub 2019 Aug 21.

25.

Synthesis of Uracil-Iodonium(III) Salts for Practical Utilization as Nucleobase Synthetic Modules.

Takenaga N, Hayashi T, Ueda S, Satake H, Yamada Y, Kodama T, Dohi AT.

Molecules. 2019 Aug 21;24(17). pii: E3034. doi: 10.3390/molecules24173034.

26.

Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine.

Ogata M, Satake H, Ogata T, Hatachi Y, Hara S, Hirota S, Yasui H.

Intern Med. 2019 Nov 15;58(22):3243-3246. doi: 10.2169/internalmedicine.2806-19. Epub 2019 Jul 22.

27.

Identification of a binding protein for sesamin and characterization of its roles in plant growth.

Tera M, Koyama T, Murata J, Furukawa A, Mori S, Azuma T, Watanabe T, Hori K, Okazawa A, Kabe Y, Suematsu M, Satake H, Ono E, Horikawa M.

Sci Rep. 2019 Jun 14;9(1):8631. doi: 10.1038/s41598-019-45003-7.

28.

Functional characterization of an invertebrate gonadotropin-releasing hormone receptor in the Yesso scallop Mizuhopecten yessoensis.

Nagasawa K, Matsubara S, Satake H, Osada M.

Gen Comp Endocrinol. 2019 Oct 1;282:113201. doi: 10.1016/j.ygcen.2019.06.005. Epub 2019 Jun 11.

PMID:
31199924
29.

Different characteristics of postoperative atrial tachyarrhythmias between congenital and non-congenital heart disease.

Kondo M, Fukuda K, Wakayama Y, Nakano M, Hasebe Y, Satake H, Segawa M, Hirano M, Shimokawa H.

J Interv Card Electrophysiol. 2019 Jun 13. doi: 10.1007/s10840-019-00575-2. [Epub ahead of print]

PMID:
31197584
30.

Peptide receptors and immune-related proteins expressed in the digestive system of a urochordate, Ciona intestinalis.

Satake H, Matsubara S, Shiraishi A, Yamamoto T, Osugi T, Sakai T, Kawada T.

Cell Tissue Res. 2019 Sep;377(3):293-308. doi: 10.1007/s00441-019-03024-8. Epub 2019 May 11. Review.

PMID:
31079207
31.

Characteristics of ventricular tachycardia and long-term treatment outcome in patients with dilated cardiomyopathy complicated by lamin A/C gene mutations.

Hasebe Y, Fukuda K, Nakano M, Kumagai K, Karibe A, Fujishima F, Satake H, Kondo M, Wakayama Y, Shimokawa H.

J Cardiol. 2019 Nov;74(5):451-459. doi: 10.1016/j.jjcc.2019.03.019. Epub 2019 May 3.

PMID:
31060954
32.

Repertoires of G protein-coupled receptors for Ciona-specific neuropeptides.

Shiraishi A, Okuda T, Miyasaka N, Osugi T, Okuno Y, Inoue J, Satake H.

Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7847-7856. doi: 10.1073/pnas.1816640116. Epub 2019 Apr 1.

33.

Monitoring of fatigue in radiologists during prolonged image interpretation using fNIRS.

Nihashi T, Ishigaki T, Satake H, Ito S, Kaii O, Mori Y, Shimamoto K, Fukushima H, Suzuki K, Umakoshi H, Ohashi M, Kawaguchi F, Naganawa S.

Jpn J Radiol. 2019 Jun;37(6):437-448. doi: 10.1007/s11604-019-00826-2. Epub 2019 Mar 19.

PMID:
30891667
34.

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study.

Ogata T, Satake H, Ogata M, Hatachi Y, Maruoka H, Yamashita D, Hashida H, Hamada M, Yasui H.

Oncotarget. 2019 Feb 1;10(10):1070-1084. doi: 10.18632/oncotarget.26626. eCollection 2019 Feb 1.

35.

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.

Tanioka H, Honda M, Tanaka C, Morita Y, Ishibashi K, Kato T, Matsuda C, Kataoka M, Satake H, Munemoto Y, Kobayashi K, Takahashi M, Nakata K, Sakamoto J, Oba K, Mishima H.

Int J Clin Oncol. 2019 Jul;24(7):836-841. doi: 10.1007/s10147-019-01414-0. Epub 2019 Feb 18.

PMID:
30778794
36.

Ultraviolet B-induced Otx2 expression in lens epithelial cells promotes epithelial-mesenchymal transition.

Yoshitomi Y, Osada H, Satake H, Kojima M, Saito-Takatsuji H, Ikeda T, Yoshitake Y, Ishigaki Y, Kubo E, Sasaki H, Yonekura H.

Biol Open. 2019 Feb 18;8(2). pii: bio035691. doi: 10.1242/bio.035691.

37.

Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors.

Sunakawa Y, Satake H, Ichikawa W.

World J Gastrointest Oncol. 2018 Dec 15;10(12):528-531. doi: 10.4251/wjgo.v10.i12.528.

38.

Acute Liver Failure with Diffuse Liver Metastasis from Breast Cancer, Not Detected by Computed Tomography: 2 Case Reports.

Ogata T, Kikawa Y, Ogata M, Satake H, Hatachi Y, Yasui H.

Case Rep Oncol. 2018 Oct 31;11(3):699-704. doi: 10.1159/000493848. eCollection 2018 Sep-Dec.

39.

Bilateral Xp11.2 translocation renal cell carcinoma: a case report.

Karashima T, Kuno T, Kuroda N, Satake H, Fukata S, Chikazawa M, Kawada C, Yamasaki I, Shuin T, Hiroi M, Inoue K.

BMC Urol. 2018 Nov 20;18(1):106. doi: 10.1186/s12894-018-0419-3.

40.

Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.

Ogata M, Hatachi Y, Ogata T, Satake H, Imai Y, Yasui H.

Intern Med. 2019 Apr 1;58(7):1029-1032. doi: 10.2169/internalmedicine.1640-18. Epub 2018 Nov 19.

41.

Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604).

Saeki H, Oki E, Kashiwada T, Arigami T, Makiyama A, Iwatsuki M, Narita Y, Satake H, Matsuda Y, Sonoda H, Shimokawa M, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC).

Eur J Cancer. 2018 Dec;105:41-49. doi: 10.1016/j.ejca.2018.09.024. Epub 2018 Nov 2.

PMID:
30391779
42.

Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study.

Ogata T, Satake H, Ogata M, Hatachi Y, Inoue K, Hamada M, Yasui H.

Oncotarget. 2018 Oct 2;9(77):34520-34527. doi: 10.18632/oncotarget.26145. eCollection 2018 Oct 2.

43.

A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group.

Kobayashi S, Nagano H, Tomokuni A, Gotoh K, Sakai D, Hatano E, Seo S, Terajima H, Uchida Y, Ajiki T, Satake H, Kamei K, Tohyama T, Hirose T, Ikai I, Morita S, Ioka T; Kansai Hepato-Biliary Oncology (KHBO) Group.

Ann Surg. 2019 Aug;270(2):230-237. doi: 10.1097/SLA.0000000000002865.

PMID:
30339627
44.

Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.

Kikawa Y, Hatachi Y, Rumpold G, Tokiwa M, Takebe S, Ogata T, Satake H, Kato H, Tsuji A, Yasui H, Holzner B.

Breast Cancer. 2019 Mar;26(2):255-259. doi: 10.1007/s12282-018-0905-1. Epub 2018 Sep 7.

45.

Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.

Satake H, Sagawa T, Fujikawa K, Hatachi Y, Yasui H, Kotaka M, Kato T, Tsuji A.

Cancer Chemother Pharmacol. 2018 Nov;82(5):839-845. doi: 10.1007/s00280-018-3678-5. Epub 2018 Aug 30.

46.

Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.

Tsuchihashi K, Ito M, Moriwaki T, Fukuoka S, Taniguchi H, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama A, Denda T, Satake H, Suto T, Sugimoto N, Katsumata K, Ishikawa T, Kashiwada T, Oki E, Komatsu Y, Okuyama H, Sakai D, Ueno H, Tamura T, Yamashita K, Kishimoto J, Shimada Y, Baba E.

Clin Colorectal Cancer. 2018 Dec;17(4):e687-e697. doi: 10.1016/j.clcc.2018.07.004. Epub 2018 Jul 29.

PMID:
30149986
47.

Lactosylceramide synthases encoded by B4galt5 and 6 genes are pivotal for neuronal generation and myelin formation in mice.

Yoshihara T, Satake H, Nishie T, Okino N, Hatta T, Otani H, Naruse C, Suzuki H, Sugihara K, Kamimura E, Tokuda N, Furukawa K, Fururkawa K, Ito M, Asano M.

PLoS Genet. 2018 Aug 16;14(8):e1007545. doi: 10.1371/journal.pgen.1007545. eCollection 2018 Aug.

48.

Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.

Nagasaka K, Satake H, Ishigaki S, Kawai H, Naganawa S.

Breast Cancer. 2019 Jan;26(1):113-124. doi: 10.1007/s12282-018-0899-8. Epub 2018 Aug 1.

PMID:
30069785
49.

A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.

Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Sudo T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.

Cancer Med. 2018 Sep;7(9):4217-4227. doi: 10.1002/cam4.1623. Epub 2018 Jul 26.

50.

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11.

Satake H, Sunakawa Y, Miyamoto Y, Nakamura M, Nakayama H, Shiozawa M, Makiyama A, Kobayashi K, Kubota Y, Mori M, Kotaka M, Takagane A, Gotoh M, Takeuchi M, Fujii M, Ichikawa W, Sekikawa T.

Oncotarget. 2018 Jul 6;9(52):30023. doi: 10.18632/oncotarget.25775. eCollection 2018 Jul 6.

Supplemental Content

Loading ...
Support Center